Word

KALEIDO

Status

Registered

Status Code

700

Status Date

Tuesday, March 23, 2021

Serial Number

88369612

Registration Number

6301922

Registration Date

Tuesday, March 23, 2021

Mark Type

3000

Filing Date

Wednesday, April 3, 2019

Published for Opposition

Tuesday, November 12, 2019

Trademark Owner History

Kaleido Biosciences, Inc. - Original Registrant

Classifications

5 Preparations and substances for pharmaceutical and medical purposes, namely, for the treatment of dysbioses, inflammatory disorders and conditions, infectious diseases, metabolic diseases, nutritional disorders, malnutrition, immune-mediated diseases, including autoimmune diseases, allergies, and immune tolerance, malignancies and cancers, neurological diseases, psychiatric conditions, gastrointestinal diseases and disorders, gastrointestinal injury conditions, digestive abnormalities, dermatological conditions, cardiovascular diseases, nephrologic diseases and conditions, including organ failure, ophthalmic disorders, vaginal and penile conditions, pediatric disorders and conditions, including growth and developmental conditions, and geriatric disorders and conditions, all of the foregoing related to the microbiome and all of the foregoing excluding treatments for cystic fibrosis; therapeutic pharmaceuticals for medical use, namely, for the treatment of dysbioses, inflammatory disorders and conditions, infectious diseases, metabolic diseases, nutritional disorders, malnutrition, immune-mediated diseases, including autoimmune diseases, allergies, and immune tolerance, malignancies and cancers, neurological diseases, psychiatric conditions, gastrointestinal diseases and disorders, gastrointestinal injury conditions, digestive abnormalities, dermatological conditions, cardiovascular diseases, nephrologic diseases and conditions, including organ failure, ophthalmic disorders, vaginal and penile conditions, pediatric disorders and conditions, including growth and developmental conditions, and geriatric disorders and conditions, all of the foregoing related to the microbiome and all of the foregoing excluding treatments for cystic fibrosis

Color is not claimed as a feature of the mark.
The mark consists of the word "KALEIDO" to the right of the stylized representation of a round kaleidoscope image.

Trademark Events

Mar 23, 2021

Registered-Principal Register

Feb 16, 2021

Notice Of Acceptance Of Statement Of Use E-Mailed

Feb 15, 2021

Allowed Principal Register - Sou Accepted

Feb 4, 2021

Statement Of Use Processing Complete

Jan 7, 2021

Use Amendment Filed

Jan 27, 2021

Case Assigned To Intent To Use Paralegal

Jan 7, 2021

Teas Statement Of Use Received

Jul 9, 2020

Notice Of Approval Of Extension Request E-Mailed

Jul 7, 2020

Extension 1 Granted

Jul 7, 2020

Extension 1 Filed

Jul 7, 2020

Teas Extension Received

Jan 7, 2020

Noa E-Mailed - Sou Required From Applicant

Nov 12, 2019

Official Gazette Publication Confirmation E-Mailed

Nov 12, 2019

Published For Opposition

Oct 23, 2019

Notification Of Notice Of Publication E-Mailed

Oct 10, 2019

Assigned To Lie

Oct 5, 2019

Approved For Pub - Principal Register

Oct 4, 2019

Teas/Email Correspondence Entered

Oct 2, 2019

Correspondence Received In Law Office

Oct 2, 2019

Teas Response To Office Action Received

Oct 2, 2019

Attorney/Dom.Rep.Revoked And/Or Appointed

Oct 2, 2019

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

Jun 14, 2019

Notification Of Non-Final Action E-Mailed

Jun 14, 2019

Non-Final Action E-Mailed

Jun 14, 2019

Non-Final Action Written

Jun 13, 2019

Assigned To Examiner

Apr 23, 2019

Notice Of Design Search Code E-Mailed

Apr 22, 2019

New Application Office Supplied Data Entered In Tram

Apr 6, 2019

New Application Entered In Tram